SetPoint Medical Raises $140M to Support Commercialization of Rheumatoid Arthritis Therapy

What You Should Know: – SetPoint Medical, a company focused on developing innovative therapies for chronic autoimmune diseases secures $140M in private financing. This includes the final $25M tranche of its Series C funding and a substantial $115M Series D round co-led by Elevage Medical Technologies and Ally Bridge Group. – The funding will fuel ... Read More